ACLA Press Releases

  • ACLA Statement on FDA’s Revised Policy for Serologic Tests  

    May 04, 2020
    WASHINGTON, D.C. –  Following the revised policy on serologic testing announced today by the Food and Drug Administration, ACLA President Julie Khani issued the following statement: “ACLA is reviewing the latest announcement by the FDA. We commend the agency for its continued diligence in evaluating the available data regarding testing options and implementing policies that promote the public’s health. It is essential that patients and clinicians canContinue Reading »...
  • ACLA Statement on White House Meeting

    April 27, 2020
    WASHINGTON, D.C. – Following today’s meeting at the White House, ACLA President Julie Khani issued the following statement: “ACLA appreciated the opportunity to meet today with President Trump, Vice President Pence and other members of the White House Coronavirus Task Force. Representing the backbone of our nation’s testing response, ACLA members have now performed 3.2 million tests and remain focused on continuing to increaseContinue Reading »...
  • ACLA Statement on the Paycheck Protection Program and Health Care Enhancement Act

    April 22, 2020
    WASHINGTON, D.C. — Following Senate passage of the Paycheck Protection Program and Health Care Enhancement Act, ACLA President Julie Khani released the following statement: ACLA commends Congress for recognizing the need to substantially increase funding and support for testing in the most recent COVID-19 legislative package. This is an important step to provide states, federal agencies and the clinical laboratory community with the resourcesContinue Reading »...
  • Clinical Labs Support Congressional Funding To Ensure Robust Testing Infrastructure

    April 20, 2020
    Federal Funding Is Needed To Ensure Laboratories Can Scale High Throughput Testing For COVID-19 Washington, D.C. – The American Clinical Laboratory Association is encouraged by reports from Congressional leaders and the Administration regarding $25 billion in funding for COVID-19 testing. Moving forward, it is critical that any funding includes robust support for commercial laboratories performing and expanding COVID-19 testing, including high throughput tests thatContinue Reading »...
  • Dave King joins ACLA as Special Advisor

    April 20, 2020
    WASHINGTON, D.C. — The American Clinical Laboratory Association (ACLA) today announced Dave King, former CEO of Laboratory Corporation of America Holdings (LabCorp), will join ACLA as a special advisor. Building on his twenty years of service to the industry, including more than a decade serving on the ACLA board, King will support the association’s strategic and tactical responses to the COVID-19 pandemic. In this role,Continue Reading »...
  • As Nation Recognizes Laboratory Professionals Week, ACLA Highlights Extraordinary Efforts of “The Laboratory People”

    April 19, 2020
    Association announces plans to highlight members’ efforts during Laboratory Professionals Week (April 19 – 25) WASHINGTON, D.C. — Today, the American Clinical Laboratory Association (ACLA) announced plans to highlight stories of laboratory researchers, technicians, administrative staff, and medical officers who are going above and beyond the call of duty to serve patients during the COVID-19 pandemic. “Tens of thousands of laboratory staff are workingContinue Reading »...
  • CMS Takes Decisive Action to Support Laboratories Responding to COVID-19 Pandemic

    April 15, 2020
    WASHINGTON, D.C. – Following the decision announced today by Centers for Medicare & Medicaid Services (CMS) to raise the Medicare reimbursement rate for high throughput COVID-19 molecular tests from about $51 to $100 dollars, ACLA President Julie Khani issued the following statement: “In an acknowledgement of the considerable strain that has been placed on clinical laboratories supporting our nation’s response to the COVID-19 pandemic,Continue Reading »...
  • ACLA President Julie Khani Outlines Key Challenges Facing Testing Capacity

    March 29, 2020
    WASHINGTON, D.C. – Today, ACLA President Julie Khani released the following statement: “One month ago today, the FDA cleared the regulatory barriers preventing commercial labs from performing COVID-19 testing. Since then, ACLA member laboratories have steadily increased COVID-19 testing capacity each week. In total, ACLA members have performed approximately 650,000 COVID-19 tests to date, including 84,000 tests completed just yesterday. We currently have six ACLAContinue Reading »...
  • ACLA Statement on CARES Act

    March 25, 2020
    WASHINGTON, D.C. – Following the release the Coronavirus Aid, Relief, and Economic Security Act this evening, ACLA President Julie Khani released the following statement: “For the third time, Congress has failed to provide the necessary funds to support ‘free testing’ for all Americans. Our members remain in an untenable situation, absorbing growing, uncompensated costs for testing specimens with no assurance that they will be appropriately or fairlyContinue Reading »...
  • With Congress on its third financial relief package, policymakers fail to recognize critical role of labs

    March 23, 2020
    WASHINGTON, D.C. — As policymakers close in on a third financial relief package, ACLA President Julie Khani issued the following statement: “We are on the cusp of the U.S. Congress finalizing a third legislative financial relief package to address the coronavirus response.  It is disappointing and alarming that Congress has not yet recognized the contributions of the lab industry and its response during this publicContinue Reading »...